BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 28893764)

  • 1. Prevalence of Cerebral Microbleeds in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Yoshioka D; Okazaki S; Toda K; Murase S; Saito S; Domae K; Miyagawa S; Yoshikawa Y; Daimon T; Sakaguchi M; Sawa Y
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28893764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of brain imaging in patients after left ventricular assist device support following explantation.
    Murase S; Okazaki S; Yoshioka D; Watanabe K; Gon Y; Todo K; Sasaki T; Sakaguchi M; Misumi Y; Toda K; Sawa Y; Mochizuki H
    J Heart Lung Transplant; 2020 Mar; 39(3):220-227. PubMed ID: 31843457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular Accidents During Mechanical Circulatory Support: New Predictors of Ischemic and Hemorrhagic Strokes and Outcome.
    Izzy S; Rubin DB; Ahmed FS; Akbik F; Renault S; Sylvester KW; Vaitkevicius H; Smallwood JA; Givertz MM; Feske SK
    Stroke; 2018 May; 49(5):1197-1203. PubMed ID: 29643259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From bench to bedside: Can the improvements in left ventricular assist device design mitigate adverse events and increase survival?
    Tarzia V; Di Giammarco G; Di Mauro M; Bortolussi G; Maccherini M; Tursi V; Maiani M; Bernazzali S; Marinelli D; Foschi M; Buratto E; Bejko J; Gregori D; Scuri S; Livi U; Sani G; Bottio T; Gerosa G
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):213-7. PubMed ID: 26548997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.
    Frontera JA; Starling R; Cho SM; Nowacki AS; Uchino K; Hussain MS; Mountis M; Moazami N
    J Heart Lung Transplant; 2017 Jun; 36(6):673-683. PubMed ID: 28110971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes.
    Baldwin AC; Sandoval E; Letsou GV; Mallidi HR; Cohn WE; Frazier OH
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):192-8. PubMed ID: 26344685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Microembolization in Left Ventricular Assist Device Associated Ischemic Events.
    Hassett CE; Cho SM; Rice CJ; Migdady I; Starling RC; Uchino K; Katzan IL
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104660. PubMed ID: 32044219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.
    Moutzouri E; Glutz M; Abolhassani N; Feller M; Adam L; Gencer B; Del Giovane C; Bétrisey S; Paladini RE; Hennings E; Aeschbacher S; Beer JH; Moschovitis G; Seiffge D; De Marchis GM; Coslovsky M; Reichlin T; Conte G; Sinnecker T; Schwenkglenks M; Bonati LH; Kastner P; Aujesky D; Kühne M; Osswald S; Fischer U; Conen D; Rodondi N
    Int J Stroke; 2023 Dec; 18(10):1219-1227. PubMed ID: 37243540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Bacteremia and Hemorrhagic Stroke in Patients With Continuous-Flow Left Ventricular Assist Device.
    Yoshioka D; Sakaniwa R; Toda K; Samura T; Saito S; Kashiyama N; Okazaki S; Domae K; Yoshikawa Y; Miyagawa S; Iso H; Sakata Y; Sawa Y
    Circ J; 2018 Jan; 82(2):448-456. PubMed ID: 28943532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
    Takahashi W; Moriya Y; Mizuma A; Uesugi T; Ohnuki Y; Takizawa S
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e528-32. PubMed ID: 23830955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Management of Acute Ischemic Strokes and the Prevalence of Large Vessel Occlusion in Left Ventricular Assist Device.
    Rice CJ; Cho SM; Zhang LQ; Hassett C; Starling RC; Uchino K
    Cerebrovasc Dis; 2018; 46(5-6):213-217. PubMed ID: 30513514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.
    Acharya D; Loyaga-Rendon R; Morgan CJ; Sands KA; Pamboukian SV; Rajapreyar I; Holman WL; Kirklin JK; Tallaj JA
    JACC Heart Fail; 2017 Oct; 5(10):703-711. PubMed ID: 28958345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.